Allergan Inc gives FY 2014 guidance in line with analysts' estimates; gives Q1 2014 guidance; EPS guidance below analysts' estimates - Conference Call


Wednesday, 5 Feb 2014 11:00am EST 

Allergan Inc:Expects FY 2014 product net sales in the range of $6.650 billion to $6.950 billion.Expects FY 2014 non-GAAP diluted earnings per share in the range of $5.36 to $5.48.Expects Q1 2014 product net sales in the range of $1.525 billion to $1.600 billion.Expects Q1 2014 non-GAAP diluted earnings per share in the range of $1.09 to $1.12.FY 2014 revenue of $6.801 billion and EPS of $5.45 - Thomson Reuters I/B/E/S.Q1 2014 revenue of $1.597 billion and EPS of $1.19 - Thomson Reuters I/B/E/S. 

Company Quote

7.278
0.0030 +0.04%
27 Mar 2015